Adult Flu Vaccines 2022-2023

Award Notice Posted

Solicitation number
75D30122D12996
Agency
Awarded
to Glaxosmithkline, LLC
Set-aside
No set-aside

Opportunity facts

Contract number
75D30122D12996 Federal IDV award
Place of performance
Durham, North Carolina 27709, United States

Notice details come from SAM.gov. Updated .

About this opportunity

This Award Notice from the Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services announces the award of contract number 75D30122D12996 to GlaxoSmithKline LLC for adult flu vaccines for 2022-2023. The contract value is $134,100,000 for supplying adult flu vaccines to support the agency's vaccination programs for the upcoming flu season. The award was made on December 20, 2021 based on the results of Request for Proposals number 75D301-22-R-72082.

Notice text

Notice of Award for Request for Proposals (RFP) 75D301-22-R-72082 for Adult Flu Vaccines 2022-2023.

Awarded contract 75D30122D12996 to GLAXOSMITHKLINE LLC for 13410000.00 on 2021-12-20.

Notice history

Notice Type Posted
Adult Flu Vaccines 2022-2023 Latest Award Notice
Adult Flu Vaccines 2022-2023 Award Notice
Adult Flu Vaccines 2022-2023 Award Notice
This notice Award Notice
Adult Flu Vaccines 2022-2023 Latest solicitation Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response Washington, District of Columbia 20024, United States · NAICS 541714 Office of the Assistant Secretary for Preparedness and Response No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity